Tag: Selective estrogen receptor degraders

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Selective estrogen receptor degraders

Global SERD Therapeutics Market: Focus on Product, Therapy, Country Data (14 Countries), and ...

Added to Collection on: 2021-04-09 09:56:15

Tags for this article:

Companies
Pharmaceutical companies
Life Sciences
Antiestrogens
Selective estrogen receptor degraders
G1 Therapeutics
Estranes
Organofluorides
Fulvestrant
Breast cancer
Novartis
Hoffmann-La Roche
Japan
United Kingdom
China

Click the tags to see associated articles and topics

View Article Details
ASCO: Sanofi says early amcenestrant data could see it be 'endocrine backbone therapy' in breast ...

Added to Collection on: 2021-05-19 21:00:00

Tags for this article:

Chemical compounds
Antiestrogens
Drugs
Organic compounds
Selective estrogen receptor degraders
Selective estrogen receptor modulators
Triphenylethylenes
Fulvestrant
Elacestrant
Brilanestrant
Palbociclib
Breast cancer

Click the tags to see associated articles and topics

View Article Details
Menarini, chased by 3 Big Pharmas, records win in breast cancer phase 3, plots path to FDA

Added to Collection on: 2021-10-21 11:34:05

Tags for this article:

Drugs
Antiestrogens
Hormones
Selective estrogen receptor degraders
Endocrine system
Selective estrogen receptor modulators
Amines
Elacestrant
Phenols
Fulvestrant
Sanofi
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Degrader battle sees Sanofi edged out for now

Added to Collection on: 2021-10-21 23:39:06

Tags for this article:

Drugs
Hormones
Antiestrogens
Endocrine system
Selective estrogen receptor degraders
Selective estrogen receptor modulators
Amines
Elacestrant
Fulvestrant
Aromatase inhibitor
Cyclin-dependent kinase 4
Breast cancer

Click the tags to see associated articles and topics

View Article Details
After setbacks for Roche and Sanofi, AZ scores oral SERD win - - Pharmaphorum

Added to Collection on: 2022-10-26 10:23:01

Tags for this article:

Chemical compounds
Organic compounds
Drugs
Antiestrogens
Protein kinase inhibitors
Piperazines
Breakthrough therapy
Selective estrogen receptor degraders
Palbociclib
Abemaciclib
Fulvestrant
Elacestrant
Faslodex

Click the tags to see associated articles and topics

View Article Details
Camizestrant extends PFS in advanced ER-positive breast cancer - Healio

Added to Collection on: 2022-10-29 16:13:33

Tags for this article:

Antiestrogens
Drugs
Selective estrogen receptor degraders
Health
Medicine
Estranes
Organofluorides
AstraZeneca
Fulvestrant
Progression-free survival
Email
Clinical endpoint

Click the tags to see associated articles and topics

View Article Details
Arvinas' Experimental Breast Cancer Drug Fails to Impress Analysts | BioSpace

Added to Collection on: 2022-11-23 20:25:48

Tags for this article:

Antiestrogens
Drugs
Hormones
Endocrine system
Selective estrogen receptor degraders
Breast cancer
Estranes
Organofluorides
Estrogen receptor
Fulvestrant
Metastatic breast cancer
arvinas inc

Click the tags to see associated articles and topics

View Article Details
Study Shows Real-World Outcomes of First-Line Palbociclib Plus Fulvestrant in HR+, HER2

Added to Collection on: 2025-01-19 03:05:37

Tags for this article:

Cyclopentanes
Lactams
Selective estrogen receptor degraders
Protein kinase inhibitors
Antiestrogens
Palbociclib
Fulvestrant
Breast cancer
HER2
CDK inhibitor
Dalpiciclib
Pfizer
AstraZeneca

Click the tags to see associated articles and topics

View Article Details